[Drug prevention of pulmonary embolism in orthopedic practice: traditional and novel approaches]
| Autor: | D V, Preobrazhenskiĭ, B A, Sidorenko, T A, Batyraliev, N I, Nekrasova |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Venous Thrombosis
Drug Substitution Heparin Drug Administration Routes Therapies Investigational Thrombin Anticoagulants Heparin Low-Molecular-Weight Postoperative Complications Lower Extremity Risk Factors Secondary Prevention Humans Orthopedic Procedures International Normalized Ratio Warfarin Pulmonary Embolism Factor Xa Inhibitors Randomized Controlled Trials as Topic |
| Zdroj: | Kardiologiia. 51(5) |
| ISSN: | 0022-9040 |
| Popis: | We consider in this review traditional and novel approaches to drug prevention of pulmonary embolism (PE) which in predominant number of cases is related to deep vein thrombosis of lower extremities. Risk of PE development is especially high in patients after orthopedic hip or knee surgery. Modern recommendations contemplate use of unfractionated and low molecular weight heparins, vitamin K antagonists (warfarin in the first place), fondaparinux. Oral direct anticoagulants related to selective inhibitors of blood coagulation factors IIa (thrombin) and Xa have appeared recently and proved their preventive efficacy and safety in randomized controlled studies. Preventive efficacy and safety of dabigatran among direct selective factor IIa (thrombin) inhibitors and of rivaroxaban, apixaban, and edoxaban among direct selective factor IIa inhibitors have been studied best. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|